Ocugen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.10

+0.06 (+2.94%)

As of Mar 23, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,327.1% upside

Low Target $22.68

Average Target $29.97

High Target $39.58

Current Price $2.10

Current
$2.10

Target
$29.97

$22.68 $29.97 avg $39.58

Scenario Analysis

Bear Case

$22.68

980.0%

Low target

Base Case

$29.97

+1,327.1%

Avg target

Bull Case

$39.58

+1,784.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.96

7.1% from high

52-Week Low

$0.52

+307.8% from low

Target vs 52W High

$29.97

+1,429.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%